Northwest Biotherapeutics Inc (NWBO) financial statements (2022 and earlier)

Company profile

Business Address 4800 MONTGOMERY LANE
BETHESDA, MD 20814
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:15100220722
Cash and cash equivalents15100220622
Other undisclosed cash, cash equivalents, and short-term investments     1 
Restricted cash and investments     11
Other undisclosed current assets2632101
Total current assets:17163241824
Noncurrent Assets
Operating lease, right-of-use asset545
Property, plant and equipment151000046
Intangible assets, net (including goodwill)22     
Goodwill11     
Intangible assets, net (excluding goodwill)11     
Restricted cash and investments      0
Other noncurrent assets1111000
Other undisclosed noncurrent assets 90 4745 
Total noncurrent assets:231761484547
TOTAL ASSETS:4033925495371
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:77616131313
Accounts payable     1212
Accrued liabilities     11
Other undisclosed accounts payable and accrued liabilities7761613  
Debt726718211
Deferred compensation liability   0   
Derivative instruments and hedges, liabilities107355203040528
Accrued environmental loss contingencies    666
Due to related parties  00705
Business combination, contingent consideration, liability887    
Other undisclosed current liabilities5911733111
Total current liabilities:1343824170887665
Noncurrent Liabilities
Long-term debt and lease obligation301312233 
Long-term debt, excluding current maturities2597233 
Operating lease, liability555
Liabilities, other than long-term debt      0
Other liabilities      0
Other undisclosed noncurrent liabilities(5)(5)  6 11
Total noncurrent liabilities:30131229311
Total liabilities:1643965372967975
Stockholders' equity
Stockholders' equity attributable to parent, including:(124)(363)(44)(47)(67)(26)(5)
Common stock1111000
Common stock, share subscribed but unissued, subscriptions receivable(0)(0)(0)(0)   
Additional paid in capital1,0671,009795776722687631
Accumulated other comprehensive income (loss)0(1)11(1)2(0)
Accumulated deficit(1,192)(1,371)(840)(824)   
Other undisclosed stockholders' equity attributable to parent    (789)(715)(635)
Other undisclosed stockholders' equity    20  
Total stockholders' equity:(124)(363)(44)(47)(47)(26)(5)
TOTAL LIABILITIES AND EQUITY:4033925495371

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues1120012
Revenue, net012
Gross profit:1120012
Operating expenses(54)(88)(30)(42)(55)(80)(128)
Operating loss:(53)(87)(27)(41)(55)(79)(126)
Nonoperating income (expense)232(443)765(12)0
Investment income, nonoperating     (6) 
Foreign currency transaction gain (loss), before tax    5(7)0
Other nonoperating income (expense)232(443)76   
Interest and debt expense(0)(4)(2)0(20)(6)(2)
Net income (loss):179(534)(22)(36)(71)(98)(128)
Other undisclosed net income (loss) attributable to parent042(0)(3)1814
Net income (loss) attributable to parent:179(530)(20)(36)(73)(80)(115)
Other undisclosed net loss available to common stockholders, basic   (18)(1)(6) 
Net income (loss) available to common stockholders, basic:179(530)(20)(54)(74)(86)(115)
Other undisclosed net loss available to common stockholders, diluted(239)      
Net loss available to common stockholders, diluted:(60)(530)(20)(54)(74)(86)(115)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):179(534)(22)(36)(71)(98)(128)
Other comprehensive income (loss)2(2)(0)2(2)20
Comprehensive income (loss):180(536)(22)(34)(73)(96)(128)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent042(0)(3)1814
Comprehensive income (loss), net of tax, attributable to parent:181(532)(20)(34)(76)(78)(115)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: